Haloperidol and Hyponatremia

Haloperidol as a Cause of Hyponatremia

"Among the agents implicated [in hyponatremia in psychotic patients] are the phenothiazines, the butyrophenone haloperidol, and the tricyclic antidepressants... although a clinical association between antipsychotic drugs and hyponatremia is frequently encountered, the pharmacologic agents themselves may not be the principal factors responsible for the water retention."

Clinical Implications

1. Haloperidol can worsen pre-existing hyponatremia - giving it to a patient who already has low sodium may further lower sodium levels.
2. Psychosis itself causes hyponatremia via:
   • Increased thirst perception (psychogenic polydipsia)
   • Mild osmoregulatory defect (AVP released at lower osmolality)
   • Enhanced renal response to vasopressin
3. Use with caution, not absolute contraindication - if haloperidol is clinically necessary (e.g., acute delirium or psychosis requiring antipsychotic treatment), it is not absolutely contraindicated in hyponatremia, but:
   • Serum sodium should be monitored closely
   • The dose should be minimized
   • Underlying hyponatremia should be corrected concurrently
   • Other contributing factors (water intake, concurrent medications) should be addressed
4. Anticholinergic effect adds risk - by drying mucous membranes, it can stimulate water intake and compound hyponatremia.
5. Hyponatremia itself causes neurological symptoms (confusion, seizures) that may be mistaken for psychiatric deterioration, leading to escalating antipsychotic doses - a dangerous feedback loop.

Summary

• Brenner & Rector's The Kidney, p. 671
• Comprehensive Clinical Nephrology 7th Ed., Table 9.2
• Bradley & Daroff's Neurology in Clinical Practice, p. 1231

Alternative Antipsychotics and Agitation Management in Hyponatremia

Important Caveat: No Antipsychotic is Fully "Safe" for Sodium

The Notable Exception: Clozapine

"Primary polydipsia generally appears resistant to antipsychotics except clozapine. Evidence-based treatment options for preventing water intoxication includes targeted fluid restriction, clozapine therapy, and removal of agents that may be causing hyponatremia."

• The Clozapine Handbook

• Mechanism: Clozapine reduces the disordered thirst drive seen in psychosis and corrects the osmoregulatory defect.
• Limitation: Clozapine is reserved for treatment-resistant schizophrenia and requires blood monitoring (agranulocytosis risk), so it is not typically a first-choice for acute agitation management.

For Acute Agitation: Preferred Agents in Hyponatremia

1. Benzodiazepines (First Choice for Acute Agitation)

• IM Midazolam 5 mg - fastest-acting, most effective single agent in a large ED trial (n=737); no known effect on sodium balance
• IM/IV Lorazepam 2 mg - established alternative, effective in combination
• No SIADH risk with benzodiazepines

"The current broad consensus is that midazolam and droperidol are the fastest-acting single-drug, intramuscular treatments and that haloperidol alone should be avoided and perhaps abandoned completely."

• Maudsley Prescribing Guidelines 15th ed.

2. Droperidol (If Antipsychotic Needed)

• IM Droperidol - equal efficacy to haloperidol for agitation; no significant reports of SIADH/hyponatremia in the literature
• Droperidol + midazolam combination was superior to haloperidol + lorazepam
• Caution: QTc prolongation risk (obtain ECG) - but hyponatremia itself also prolongs QTc, so monitor

3. Olanzapine (Second-Generation, if Antipsychotic Preferred)

• IM Olanzapine 10 mg - equal efficacy to haloperidol for agitation, fewer extrapyramidal side effects (EPSEs)
• Hyponatremia has been reported but is rare (case reports only)
• Do not combine IM olanzapine with IM benzodiazepine (risk of cardiorespiratory depression)

4. Aripiprazole (Least Prolactin/Metabolic Effects)

• IM aripiprazole is less effective than IM olanzapine at 2 hours but comparable at 24 hours
• Case reports of SIADH exist but appear rare

Practical Summary Table

Bottom Line

• For acute agitation in a hyponatremic patient: prefer IM midazolam or lorazepam first. If an antipsychotic is needed, IM olanzapine or droperidol are better choices than haloperidol.
• For long-term management in a patient with polydipsia-driven hyponatremia: clozapine is the only antipsychotic with evidence of sodium normalization.
• Monitor sodium closely with any antipsychotic initiated in a hyponatremic patient.
• Maudsley Prescribing Guidelines in Psychiatry, 15th ed., pp. 87-89
• The Clozapine Handbook, pp. 36-38
• Comprehensive Clinical Nephrology 7th ed., Table 9.2

Your Plan: Haloperidol 0.25 mg PO BID for Delirium in Hyponatremia (Na 125, being corrected)

The Dose You're Using is Guideline-Supported

"Low-dose haloperidol (1 to 2 mg PO every 4 hours as needed, or 0.25 to 0.5 mg PO every 4 hours for older adults) is the treatment of choice in cases where medications are necessary."

• At the very low end of the recommended elderly/frail range
• Well below the threshold of 3.5 mg/day where EPS risk increases meaningfully
• Far below the 4.5 mg/day threshold where EPS exceeds atypical antipsychotics

Why This is Acceptable Despite Na = 125

Key Monitoring Points

1. Recheck serum Na every 6-8 hours while correcting - target correction rate 6-8 mEq/L/24h (max 10 mEq/L/24h to avoid ODS)
2. If Na is not rising as expected - consider whether haloperidol is contributing and consider stopping it
3. Watch QTc - hyponatremia itself prolongs QTc; haloperidol adds further prolongation. A baseline ECG is prudent
4. If delirium worsens despite Na correction - reassess for other causes (infection, medications, occult structural lesion)
5. Discontinue as soon as delirium resolves - shortest possible duration is the goal

One Alternative Worth Knowing

• Kaplan & Sadock's Comprehensive Textbook of Psychiatry, p. 7034

Quetiapine 12.5 mg for Delirium: Assessment

Direct Guideline Support for This Dose

"Low-dose risperidone (0.25-0.5 mg) or quetiapine (12.5-50 mg at night to take advantage of sedation) may be effective; more sedating antipsychotics and benzodiazepines should be avoided unless the goal is to put the patient to sleep."

What the Evidence Shows

• RR for preventing delirium = 0.61 (95% CI 0.45-0.83, p=0.001) - a 39% reduction
• Duration of delirium significantly shorter (SMD -1.21, p=0.006)
• Dose range studied: 12.5-75 mg/day - your dose is within the studied range
• Adverse effects absent in 4 out of 6 studies, minimal in the other 2

Quetiapine 12.5 mg vs. Haloperidol 0.25 mg BID: Head-to-Head Comparison

The One Practical Caution with Quetiapine Here

Bottom Line

• Prefer quetiapine 12.5 mg QHS if the patient has sleep-wake cycle inversion (hyperactive at night, drowsy in day) - its sedation is a feature, not a bug
• Prefer haloperidol 0.25 mg BID if the patient is hypotensive, volume-depleted, or needs daytime behavioral control without sedation

• Harrison's Principles of Internal Medicine 22nd ed. (2025), p. 3932
• Kaplan & Sadock's Comprehensive Textbook of Psychiatry, p. 7035
• Donthu et al. 2025, Meta-analysis, PMID 41129866